BURLINGAME, CA, Hinge Bio, a privately-held biotechnology company, announced the close of a Series A financing.
Hinge Bio, Inc., a privately-held biotechnology company, announced the close of a Series A financing led by Point72. Joining Point72 are Ridgeback Capital, InVivium Capital, and Lightswitch Capital, among others.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
